[go: up one dir, main page]

DK108281C - Process for the preparation of 17α, 21-dihydroxy steroids or 21-esters thereof. - Google Patents

Process for the preparation of 17α, 21-dihydroxy steroids or 21-esters thereof.

Info

Publication number
DK108281C
DK108281C DK115064AA DK115064A DK108281C DK 108281 C DK108281 C DK 108281C DK 115064A A DK115064A A DK 115064AA DK 115064 A DK115064 A DK 115064A DK 108281 C DK108281 C DK 108281C
Authority
DK
Denmark
Prior art keywords
esters
preparation
dihydroxy steroids
steroids
dihydroxy
Prior art date
Application number
DK115064AA
Other languages
Danish (da)
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Application granted granted Critical
Publication of DK108281C publication Critical patent/DK108281C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK115064AA 1959-10-12 1960-10-11 Process for the preparation of 17α, 21-dihydroxy steroids or 21-esters thereof. DK108281C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84559459A 1959-10-12 1959-10-12
US84559559A 1959-10-12 1959-10-12
US84566159A 1959-10-12 1959-10-12

Publications (1)

Publication Number Publication Date
DK108281C true DK108281C (en) 1967-11-06

Family

ID=27420319

Family Applications (1)

Application Number Title Priority Date Filing Date
DK115064AA DK108281C (en) 1959-10-12 1960-10-11 Process for the preparation of 17α, 21-dihydroxy steroids or 21-esters thereof.

Country Status (7)

Country Link
BE (1) BE595971A (en)
CH (1) CH392500A (en)
DE (1) DE1188079B (en)
DK (1) DK108281C (en)
FR (2) FR1428454A (en)
GB (2) GB959377A (en)
NL (1) NL6810178A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069322A (en) * 1976-10-12 1978-01-17 Interx Research Corporation Pro-drugs for the improved delivery of certain selected anti-inflammatory steroids
EP2805720B1 (en) 2008-05-28 2019-08-07 ReveraGen BioPharma, Inc. Non-hormonal steroid modulators of NF-KB for treatment of disease
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc Non-hormonal steroid modulators of nf- kappa b for treatment of disease
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2866799A (en) * 1957-01-02 1958-12-30 Merck & Co Inc Method for converting a 17-20, 20-21 bismethylenedioxy or a 17-20, 20-21 bis-substituted methylenedioxy steroid of the pregnane series to a 17alpha, 21-dihydroxy-20-ketosteroid of the pregnane series

Also Published As

Publication number Publication date
BE595971A (en) 1961-02-01
DE1188079B (en) 1965-03-04
CH392500A (en) 1965-05-31
GB959378A (en) 1964-06-03
FR957M (en) 1961-11-27
GB959377A (en) 1964-06-03
NL6810178A (en) 1968-10-25
FR1428454A (en) 1966-02-18

Similar Documents

Publication Publication Date Title
DK103510C (en) Process for the preparation of 3-oxo-Δ <1> -10α-methyl steroids from the androstane series or from the pregnane series.
DK108281C (en) Process for the preparation of 17α, 21-dihydroxy steroids or 21-esters thereof.
DK105020C (en) Process for the preparation of 21-dihydrogen phosphates of 16α, 17α-acetals or ketals of 6-halo-4-pregnene-16α, 17α, 21-triol-3,20-diones or alkali metal salts thereof.
DK118874B (en) Process for the preparation of 9α, 11β-dihalosteroids of the pregnane or androstane series.
DK105528C (en) Process for the preparation of 6α, 16α-dimethyl-11-oxygenated-1,4-pregnadiene-17α, 21-diol-3,20-dione compounds.
DK119556B (en) Process for the preparation of 9α-fluoro-16β-methyl derivatives of hydrocortisone or prednisolone or 21-acetates thereof.
DK108860C (en) Process for the preparation of 11-oxygenated 6α-fluoro-9α-halogen-16β-methyl-1,4-pregnadiene-17α, 21-diol-3,20-diones or 21-esters thereof.
DK119156B (en) Process for the preparation of 6α-methyl-16-methylene steroids from the pregnane series.
DK98178C (en) Process for the preparation of 9α-fluoro-16-methylene-1,4-pregnadiene-11β, 17α, 21-triol-3,20-dione or 21-esters thereof.
DK105019C (en) Process for the preparation of 6α-chloro- or 6α-bromo-9α-fluor-16α-methyl-Δ <1,4> -pregnadiene-17α, 21-diol-3,20-diones or esters thereof.
DK98495C (en) Process for the preparation of 16α, 17α-acetals or ketals of 6-halo-4-pregnene-16α, 17α-diol-3,20-dione.
DK95172C (en) Process for the preparation of 2-alkyl-11β, 17α, 21-trihydroxy-4-pregnene-3,20-diones or 21-esters thereof.
DK100813C (en) Process for the preparation of Δ <4.6> or Δ <1,4.6> -3-keto-6-halogen steroids of the androstane or pregnane series.
DK106608C (en) Process for the preparation of 16α-chloromethyl-Δ <1,4> -pregnadiene-11β, 21-diol-3,20-dione or 21-esters thereof.
DK94891C (en) Process for the preparation of 21-hydroxy-A-nor-progesterone or 21-esters thereof.
DK98002C (en) Process for the preparation of 11β, 17α, 21-trihydroxy-16α-methyl-4-pregnene-3,20-dione.
DK107290C (en) Process for the preparation of 16-methylene steroids.
DK97940C (en) Process for the preparation of 16-halomethylene-1,4-pregnadiene compounds or 21-esters thereof.
DK128606B (en) Process for the preparation of 16β-methylprednisone or its 21-acetate.
DK118556B (en) Analogous process for the preparation of 16α-methyl-9α-chloro-Δ <1,4> -pregnadiene-11β, 21-diol-3,20-diones or 21-esters thereof.
DK89681C (en) Process for the preparation of 16α, 21-dialkanoyloxy-17α-hydroxy-9β, 11β-oxido-1,4-pregnadiene-3,20-diones.
DK89185C (en) Process for the preparation of 17α, 21-dihydroxy-20-keto-steroids of the pregnane series.
DK99745C (en) Process for the preparation of 11β, 17α, 21-trihydroxy-6α, 16α-dimethyl-4-pregnene- or -1,4-pregnadiene-3,20-dione.
DK95318C (en) Process for the preparation of 17α-acyloxy-6-methyl-16-methylene-4,6-pregnadiene-3,20-diones.
DK93348C (en) Process for the preparation of 6-methyl-17α-acyloxy-4,6-pregnadiene-3,20-diones.